Literature DB >> 16417961

Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility?

Th H van der Kwast.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417961     DOI: 10.1016/j.eururo.2005.12.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical recurrence in pT2pN0R0 prostate cancer.

Authors:  Okyaz Eminaga; Mahmoud Abbas; Olaf Bettendorf; Axel Semjonow
Journal:  World J Urol       Date:  2020-06-26       Impact factor: 4.226

2.  In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.

Authors:  Yujiro Ito; Emily A Vertosick; Daniel D Sjoberg; Andrew J Vickers; Hikmat A Al-Ahmadie; Ying-Bei Chen; Anuradha Gopalan; Sahussapont J Sirintrapun; Satish K Tickoo; James A Eastham; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

3.  Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Mark K Buyyounouski; Peter L Choyke; Jesse K McKenney; Oliver Sartor; Howard M Sandler; Mahul B Amin; Michael W Kattan; Daniel W Lin
Journal:  CA Cancer J Clin       Date:  2017-02-21       Impact factor: 508.702

4.  Should pathologists continue to use the current pT2 substaging system for reporting of radical prostatectomy specimens?

Authors:  Athanase Billis; Luciana L Meirelles; Leandro L L Freitas; Luis A Magna; Leonardo O Reis; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2011-02-20       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.